Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Protara Therapeutics Inc’s stock clocked out at $3.10, up 5.98% from its previous closing price of $2.92. In other words, the price has increased by $5.98 from its previous closing price. On the day, 0.78 million shares were traded. TARA stock price reached its highest trading level at $3.16 during the session, while it also had its lowest trading level at $2.87.
Ratios:
To gain a deeper understanding of TARA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.17 and its Current Ratio is at 11.17. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On June 04, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $40.
On February 17, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $43.Oppenheimer initiated its Outperform rating on February 17, 2021, with a $43 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 35444780 and an Enterprise Value of -24668106.
Stock Price History:
The Beta on a monthly basis for TARA is 1.79, which has changed by -0.015873015 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, TARA has reached a high of $5.24, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -16.48%, while the 200-Day Moving Average is calculated to be 28.80%.
Shares Statistics:
It appears that TARA traded 261.15K shares on average per day over the past three months and 343040 shares per day over the past ten days. A total of 11.36M shares are outstanding, with a floating share count of 9.16M. Insiders hold about 19.88% of the company’s shares, while institutions hold 68.80% stake in the company. Shares short for TARA as of 1713139200 were 398338 with a Short Ratio of 1.53, compared to 1710460800 on 61442. Therefore, it implies a Short% of Shares Outstanding of 398338 and a Short% of Float of 5.29.
Earnings Estimates
The dynamic stock of Protara Therapeutics Inc (TARA) is currently being evaluated by a team of 4.0 analysts, each contributing to its current rating.On average, analysts expect EPS of -$0.92 for the current quarter, with a high estimate of -$0.64 and a low estimate of -$1.07, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.8, with high estimates of -$0.46 and low estimates of -$1.12.
Analysts are recommending an EPS of between -$1.97 and -$5.35 for the fiscal current year, implying an average EPS of -$3.64. EPS for the following year is -$3.73, with 5.0 analysts recommending between -$1.69 and -$5.95.
